Companies: 10,795·Total market cap: $144.5T
Organogenesis Holdings Inc.

Organogenesis Holdings Inc.

ORGONASDAQHealthcare● Active
$2.38
$-0.04(-1.65%)
Market Cap$306245424
P/E Ratio
52W High$7.077
52W Low$2.04
Overview

Organogenesis Holdings Inc.(ORGO)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ORGO · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.56B$0.48B$0.43B$0.45B$0.47B
Cost of Revenue$0.14B$0.12B$0.11B$0.11B$0.11B
Gross Profit$0.43B$0.37B$0.33B$0.35B$0.35B
Gross Margin %(computed)75.57%75.99%75.42%76.71%75.57%
Operating Expenses
R&D Expenses$0.04B$0.05B$0.04B$0.04B$0.03B
G&A Expenses$0.00B$0.29B$0.26B$0.28B$0.00B
Total Operating Expenses$0.37B$0.37B$0.31B$0.32B$0.28B
Operating Income$0.06B($0.00B)$0.01B$0.02B$0.07B
Operating Margin %(computed)9.92%-0.27%2.89%4.95%15.45%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.01B
Income Before Tax$0.05B($0.00B)$0.01B$0.02B$0.06B
Income Tax Expense$0.01B($0.00B)$0.01B$0.00B($0.03B)
Net Income$0.04B$0.00B$0.00B$0.02B$0.09B
Net Margin %(computed)6.58%0.18%1.14%3.44%20.16%
Per Share & EBITDA
EPS (Basic)$0.16$-0.01$0.04$0.12$0.73
Wtd Avg Shares0.13B0.13B0.13B0.13B0.13B
EBITDA$0.08B$0.02B$0.04B$0.04B$0.09B
EBITDA Margin %(computed)14.71%3.27%8.32%8.94%18.61%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Organogenesis Holdings Inc.

关于Organogenesis Holdings Inc.(ORGO)损益表

Organogenesis Holdings Inc.(ORGO)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,ORGO实现营收$0.56B,毛利润$0.43B(毛利率75.57%),净利润$0.04B(净利率6.58%)。

常见问题

ORGO · 4 问

Organogenesis Holdings Inc.(ORGO)2025财年营收为$0.56B,同比up16.8%。

ORGO revenueORGO salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08